Tarsal hydrarthrosis in the horse: response to intra-articular injection of synthetic steroids.

This research investigates the effects of intra-articular injection of synthetic steroids on horses suffering from tarsal hydrarthrosis (bog spavin). It assesses the clinical response and changes in synovial effusion in affected horses, and compares preinjection and postinjection analyses of synovial fluid.

Understanding Tarsal Hydrarthrosis

• Tarsal hydrarthrosis, more commonly known as bog spavin, is a condition in horses which causes chronic distension (swelling) in certain synovial sacs within their tarsal joints.
• This condition primarily affects the tibiotarsal synovial sac, along with the proximal intertarsal synovial sac to a lesser extent. Both sacs communicate and an excessive overflow of synovial fluid (effusion) in one results in overflow in the other.
• Common symptoms include a noticeable distention of certain pouches in the tibiotarsal synovial sac due to excessive synovial effusion.
• Bog spavin is most prevalent in young horses and its onset could be sudden or develop gradually over time. It can occur in one or both of the horse’s hind legs.

Intra-articular Injection Therapy

• In this research, the scientists examined the use of intra-articular injections of synthetic analogues of adrenocortical steroids as a possible treatment option for this condition.
• These steroids were seen as a potentially efficacious method to control and reduce the overproduction of synovial fluid in the affected synovial sacs in the horse’s tarsal joint.
• Arthrocentesis, a procedure wherein a needle is put into a joint to collect synovial fluid or to administer medications, was used in their administration of the synthetic steroids.
• The goal of these treatments was to manage and prevent the recurrence of the synovial effusion, thereby alleviating the pronounced distention in the tibiotarsal and proximal intertarsal synovial sacs.

The Study and Its Results

• The study strictly focused on horses with tarsal hydrarthrosis, excluding those with other joint-related diseases.
• To evaluate the efficacy of the treatment, the researchers compared data from preinjection and postinjection analyses of synovial fluid in affected horses. They also compared these results with synovial fluid analysis from control horses without the condition.
• Treating this condition effectively is important because it helps improve the health and mobility of horses, particularly those used in activities where optimum physical performance is critical.